Airway microbiota across age and disease spectrum in cystic fibrosis ET Zemanick, BD Wagner, CE Robertson, RC Ahrens, JF Chmiel, ... European Respiratory Journal 50 (5), 2017 | 228 | 2017 |
Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations ET Zemanick, JK Harris, BD Wagner, CE Robertson, SD Sagel, ... PloS one 8 (4), e62917, 2013 | 202 | 2013 |
Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study MD Bellin, T Laguna, J Leschyshyn, W Regelmann, J Dunitz, JA Billings, ... Pediatric diabetes 14 (6), 417-421, 2013 | 198 | 2013 |
Oral glucose tolerance testing in children with cystic fibrosis KL Ode, B Frohnert, T Laguna, J Phillips, B Holme, W Regelmann, ... Pediatric diabetes 11 (7), 487-492, 2010 | 131 | 2010 |
Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis LA McCauley, W Thomas, TA Laguna, WE Regelmann, A Moran, ... Annals of the American Thoracic Society 11 (2), 198-204, 2014 | 107 | 2014 |
Challenges in translating plasma proteomics from bench to bedside: update from the NHLBI Clinical Proteomics Programs RE Gerszten, F Accurso, GR Bernard, RM Caprioli, EW Klee, GG Klee, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 295 (1 …, 2008 | 88 | 2008 |
Managing diabetes in cystic fibrosis TA Laguna, BM Nathan, A Moran Diabetes, Obesity and Metabolism 12 (10), 858-864, 2010 | 64 | 2010 |
Airway microbiota in bronchoalveolar lavage fluid from clinically well infants with cystic fibrosis TA Laguna, BD Wagner, CB Williams, MJ Stevens, CE Robertson, ... PloS one 11 (12), e0167649, 2016 | 62 | 2016 |
The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population BD Wagner, FJ Accurso, TA Laguna Journal of Cystic Fibrosis 9 (3), 212-216, 2010 | 59 | 2010 |
Recent trends in cystic fibrosis-related diabetes BM Nathan, T Laguna, A Moran Current Opinion in Endocrinology, Diabetes and obesity 17 (4), 335-341, 2010 | 54 | 2010 |
Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation TA Laguna, CS Reilly, CB Williams, C Welchlin, CH Wendt Pediatric pulmonology 50 (9), 869-877, 2015 | 53 | 2015 |
Impaired fasting glucose in cystic fibrosis BI Frohnert, KL Ode, A Moran, BM Nathan, T Laguna, B Holme, ... Diabetes care 33 (12), 2660-2664, 2010 | 42 | 2010 |
SPLUNC1: a novel marker of cystic fibrosis exacerbations S Khanal, M Webster, N Niu, J Zielonka, M Nunez, G Chupp, MD Slade, ... European Respiratory Journal 58 (5), 2021 | 32 | 2021 |
Comparison of quantitative sweat chloride methods after positive newborn screen for cystic fibrosis TA Laguna, N Lin, Q Wang, B Holme, J McNamara, WE Regelmann Pediatric pulmonology 47 (8), 736-742, 2012 | 31 | 2012 |
Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation TA Laguna, BD Wagner, B Starcher, HK Luckey Tarro, SA Mann, ... Pediatric pulmonology 47 (9), 856-863, 2012 | 30 | 2012 |
Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis TA Laguna, BD Wagner, HK Luckey, SA Mann, SD Sagel, W Regelmann, ... Chest 136 (6), 1561-1568, 2009 | 30 | 2009 |
Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis TA Laguna, CB Williams, KR Brandy, C Welchlin-Bradford, CE Moen, ... Journal of Cystic Fibrosis 14 (3), 334-340, 2015 | 27 | 2015 |
The need for vigilance: the case of a false-negative newborn screen for cystic fibrosis CT Dunn, MM Skrypek, ALR Powers, TA Laguna Pediatrics 128 (2), e446-e449, 2011 | 27 | 2011 |
Increased adherence to CFF practice guidelines for pulmonary medications correlates with improved FEV1 BM Moore, TA Laguna, M Liu, JJ McNamara Pediatric pulmonology 48 (8), 747-753, 2013 | 24 | 2013 |
Decreased total serum coenzyme-Q10 concentrations: a longitudinal study in children with cystic fibrosis TA Laguna, MK Sontag, I Osberg, JS Wagener, FJ Accurso, RJ Sokol The Journal of pediatrics 153 (3), 402-407. e1, 2008 | 23 | 2008 |